Acute alcoholic hepatitis: Difference between revisions

Line 60: Line 60:


==Management==
==Management==
Abstinence from alcohol, nutritional supplementation (thiamine, folate
*Control of withdrawal symptoms
*Nutritional support for malnutrition: especially thiamine, folate, pyridoxine, magnesium, phosphate, glucose, and protein
 
High risk, severe cases
*Steroids
*Pentoxifylline
 
==Prognosis==
*Maddrey Discriminant Function score ([http://www.mdcalc.com/maddreys-discriminant-function-for-alcoholic-hepatitis/ MDF])
*Model for End-Stage Liver Disease score ([http://www.mdcalc.com/meld-score-model-for-end-stage-liver-disease-12-and-older/ MELD])
*High risk: MDF ≥ 32, MELD ≥ 18, or presence of hepatic encephalopathy
 
==Disposition==
==Disposition==



Revision as of 22:06, 19 January 2016

Background

Acute alcoholic hepatitis is inflammatory liver disease secondary to alcohol use.

  • spectrum from hepatic steatosis to alcoholic hepatitis to cirrhosis
  • history of (usually chronic) alcohol abuse (~80 grams of ethanol daily for 5 years (2))
  • ranges from subclinical cases to severe multisystem dysfunction

Clinical Features

Symptoms

  • abdominal pain
  • N/V
  • weight loss / fatigue / anorexia

Signs

  • RUQ tenderness
  • jaundice
  • fever
  • hepatomegaly
  • ascites
  • encephalopathy
  • spider angioma
  • GI bleed/varices
  • malnutrition
  • symptoms of alcohol withdrawal

Cirrhosis is found in 50-60% of cases of alcoholic hepatitis (2).

Differential Diagnosis

  • viral hepatitis
  • acetaminophen toxicity
  • alcoholic pancreatitis
  • gallstones
  • Budd-Chiari syndrome

Diagnosis

Diagnosis is difficult and relies on a good history (1).

  1. History of significant alcohol intake
  2. Clinical evidence of liver disease
  3. Supporting laboratory abnormalities
  • May be nondiagnostic in patients with mild disease or early cirrhosis


Work Up

Labs

  • CBC
    • Leukocytosis with elevated ANC
  • Chemistry including magnesium and phosphate
  • LFTs
    • Elevated AST/ALT (characteristically >2:1 and < 500 IU/L)
    • GGT alone is less reliable (low sensitivity and specificity)
  • Coagulation factors
    • Elevated PT/INR
  • Lipase if suspect pancreatitis
  • Consider hepatitis panel

Imaging

Consider transabdominal ultrasound if concern for:

  • Biliary obstruction
  • Budd-Chiari syndrome
  • Hepatic or biliary neoplasms

Management

  • Control of withdrawal symptoms
  • Nutritional support for malnutrition: especially thiamine, folate, pyridoxine, magnesium, phosphate, glucose, and protein

High risk, severe cases

  • Steroids
  • Pentoxifylline

Prognosis

  • Maddrey Discriminant Function score (MDF)
  • Model for End-Stage Liver Disease score (MELD)
  • High risk: MDF ≥ 32, MELD ≥ 18, or presence of hepatic encephalopathy

Disposition

See Also

External Links

References

  1. Amini, Maziyar; Runyon, Bruce. "Alcoholic Hepatitis 2010: A clinician's Guide to Diagnosis and Therapy." World of Gatstroenterol 2010 October 21; 16(39):4905-4912
  2. Basra, Gurjot,et. al. "Symptoms and Signs of Acute Alcoholic Hepatitis." World J Hepatol. 2011 May 27; 3(5): 118–120.